Placental Dysfunction and Congenital Heart Disease: Investigating the Placenta‐Heart Axis
Prenatal Diagnosis · 2026
DOI: 10.1002/pd.70194 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prenatal Diagnosis, 2026. Verfasst von Natalie Lanners und 10 weiteren Autor:innen. Beteiligte Einrichtung: McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA. Hauptthemen laut MEDLINE: Heart Defects, Congenital, Placenta, Placenta Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Concurrent development of the placenta and heart during early gestation suggests a shared biological basis for the co‐occurrence of abnormal placentation and congenital heart disease (CHD). This study investigated the association between placental vascular pathology and CHD type.
Methods
A retrospective study at two institutions included CHD ( n = 521) and unaffected ( n = 122) infants. CHDs were categorized into three groups (left and right ventricular outflow tract obstruction and mixed lesions) based on the anticipated effect of placental venous return streaming toward the fetal brain. Placental pathological findings were categorized by the Amsterdam criteria. The rate of placental pathology was compared between cases and controls and across the three CHD groups.
Results
CHD had higher rates of maternal vascular malperfusion (MVM) (0.31 vs. 0.05, p < 0.001). Comparison within CHD groups demonstrated similar rates of MVM, while fetal vascular malperfusion (FVM) was significantly higher in groups with reduced fetal cerebral oxygenation ( p = 0.037). MVM was associated with low birth weight (OR = 0.28, p < 0.001), and FVM was associated with increased maternal age (OR = 1.07, p = 0.037). No significant associations were identified in other placental pathologies.
Conclusion
This study offers valuable insights into the connection between placental dysfunction and CHD, identifying that MVM is significantly associated with CHD development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
- Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Pediatrics, Division of Newborn Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.
- Department of Pediatrics, Division of Neonatal-Perinatal Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
- Department of Pathology, Boston Children's Hospital, Boston, Massachusetts, USA.
- Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Natalie Lanners, Sarah U Morton, Christina Ronai, Louise Wilkins-Haug, Jacqueline G Parchem
Zitieren
APA
Lanners, N., Morton, S. U., Le, K., Blanco, S., Mansoorshahi, S., Carreon, C. K., Ronai, C., Wilkins-Haug, L., Annavajjhala, V., Parchem, J. G., & Findley, T. O. (2026). Placental Dysfunction and Congenital Heart Disease: Investigating the Placenta‐Heart Axis. Prenatal Diagnosis. https://doi.org/10.1002/pd.70194
Vancouver
Lanners N, Morton SU, Le K, Blanco S, Mansoorshahi S, Carreon CK, et al. Placental Dysfunction and Congenital Heart Disease: Investigating the Placenta‐Heart Axis. Prenatal Diagnosis. 2026. doi:10.1002/pd.70194
BibTeX
@article{Lanners2026,
author = {Lanners, Natalie and Morton, Sarah U and Le, Katherine and Blanco, Steffy and Mansoorshahi, Sara and Carreon, Chrystalle Katte and Ronai, Christina and Wilkins-Haug, Louise and Annavajjhala, Vidhya and Parchem, Jacqueline G and Findley, Tina O},
title = {Placental Dysfunction and Congenital Heart Disease: Investigating the Placenta‐Heart Axis},
journal = {Prenatal Diagnosis},
year = {2026},
doi = {10.1002/pd.70194}
}
EUVIMED